Robert J. Holt
University of Puerto Rico
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert J. Holt.
Annals of Pharmacotherapy | 1983
Robert J. Holt; César O. Freytes
Warfarin, a coumarin anticoagulant, acts by interfering with the hepatic synthesis of the vitamin-K-dependent clotting factors. It is used clinically in the treatment or prophylaxis of venous thrombosis and embolisms. Resistance to the effects of the coumarin and indanedione anticoagulants has been reported in rats and man, but its incidence has been defined as extremely rare. Resistance has been described as relative, acquired, or hereditary. The first well-documented case was also the first report to identify a genetic basis for this resistance. Since that time, there has been only one other study that strengthened the evidence for a hereditary transmission, and only a few other reports have suggested hereditary influence as a reason for coumarin resistance. In this report, a patient who presented with a familial-type warfarin resistance is described. A discussion of previous reports and possible mechanisms for nonfamilial warfarin resistance is also included.
Annals of Pharmacotherapy | 1981
Robert J. Holt; John D. Gaskins
A 59-year-old patient with acute pancreatitis is described, whose treatment was complicated by concomitant diabetes mellitus and arterial hypertension. He received propranolol and insulin without subsequent problems; however, when the insulin was changed to chlorpropamide, a significant increase in blood sugar occurred. It was postulated that this increase in blood sugar was due to an antagonistic action of propranolol at the pancreatic level which interfered with the action of chlorpropamide.
Annals of Pharmacotherapy | 1997
Robert J. Holt; Stéphane Allard
I. Le Y, Rana KZ. Dudley MN. Amphotericin B-associatedhypertension. Ann Pharmacother 1996;30:765-7. 2. Katz BZ, Cohn RA. Amphotericin B and hypertension. Pediatr Infect Dis J 1994;13:839-40. 3. Omizo MKN, Bryant RE, Loveless MO. Amphotericin B-induced malignanthypertension. Clin Infect Dis 1993;17:817-8. 4. Dukes CS, Perfect JR. AmphotericinB-induced malignanthypertensive episodes.J Infect Dis 1990;161 :588. 5. SawayaBP, WeihprechtH, CampbellWR, LorenzIN, Webb RC, Briggs JP. et al. Direct vasoconstriction as a possible cause for amphotericin B-induced nephrotoxicity in rats. J Clin Invest 1991 ;87:2097-107. 6. Vann Jones J. Differentiation and investigation of primary versus secondary hypertension(Cushingreflex).Am J Cardiol 1989;63:IOC-3C.
Annals of Pharmacotherapy | 1982
Robert J. Holt
Two patients who presented with unusual cutaneous reactions attributed to quinidine are described. One had a diffuse nonpruritic macular rash, and the other had a localized pruritis without cutaneous manifestations. Both resolved upon de-challenge with quinidine. Disopyramide phosphate was substituted for quinidine in both cases, without subsequent problems.
Annals of Pharmacotherapy | 1981
Robert J. Holt; Martin Gorrochategui; Casilda Perez
Pharmacotherapy | 1984
Robert J. Holt
Annals of Pharmacotherapy | 1984
Robert J. Holt
American pharmacy | 1982
Robert J. Holt; John D. Gaskins
American Journal of Psychiatry | 1981
Robert J. Holt; John D. Gaskins
Annals of Pharmacotherapy | 2006
Robert J. Holt